Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03002
Species: Homo sapiens
Position : chr8:67740000-67741000
Year: 2018
Title: Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  29113912
MONDO: MONDO:0007256
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Primary Human Hepatocellular Carcinoma Cells
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay; Endogenous enhancer perturbation; In vivo functional validation
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: qRT-PCR, and ChIP-qPCR; ChIP; RT-qPCR; Western blot; shRNA knockdown; Mouse genetic deletion/knock-in; In vivo phenotyping; Xenograft/xenotransplant
About Target Gene
Target gene : ANGPT2
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer